{"id":"https://openalex.org/W7225735709","doi":"https://doi.org/10.25251/vh2hky50","title":"Denifanstat, a fatty acid synthase inhibitor achieved significant clinical improvement in moderate-to-severe acne vulgaris: a review of mechanistic and clinical data","display_name":"Denifanstat, a fatty acid synthase inhibitor achieved significant clinical improvement in moderate-to-severe acne vulgaris: a review of mechanistic and clinical data","publication_year":2026,"publication_date":"2026-11-10","ids":{"openalex":"https://openalex.org/W7225735709","doi":"https://doi.org/10.25251/vh2hky50"},"language":"en","primary_location":{"id":"doi:10.25251/vh2hky50","doi":"https://doi.org/10.25251/vh2hky50","is_oa":true,"landing_page_url":"https://doi.org/10.25251/vh2hky50","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://doi.org/10.25251/vh2hky50","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5049756958","display_name":"Julie C Harper","orcid":"https://orcid.org/0000-0001-7181-8721","observed_orcids":["https://orcid.org/0000-0001-7181-8721"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Julie Harper","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161386436","display_name":"Shipra Vinod Gupta","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shipra Vinod Gupta","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007379077","display_name":"Wen-Wen Tsai","orcid":"https://orcid.org/0009-0001-1484-8016","observed_orcids":["https://orcid.org/0009-0001-1484-8016"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wen-Wen Tsai","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161390948","display_name":"Marie O'Farrel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marie O'Farrel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5161379871","display_name":"Andreas Grauer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Andreas Grauer","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5049109616","display_name":"Jonathan Weiss","orcid":"https://orcid.org/0009-0008-8824-4814","observed_orcids":["https://orcid.org/0009-0008-8824-4814"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jonathan Weiss","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"10","issue":"6","first_page":"s818","last_page":"s818"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12465","display_name":"Cancer, Lipids, and Metabolism","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C48289651","wikidata":"https://www.wikidata.org/wiki/Q106916817","display_name":"Fatty acid synthase","level":3,"score":0.6678000092506409},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5573999881744385},{"id":"https://openalex.org/C141359234","wikidata":"https://www.wikidata.org/wiki/Q2734301","display_name":"Lipogenesis","level":3,"score":0.5388000011444092},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5307000279426575},{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.5299000144004822},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.5113000273704529},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4772000014781952},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.47360000014305115},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.4154999852180481},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.4117000102996826},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4074999988079071},{"id":"https://openalex.org/C2779936771","wikidata":"https://www.wikidata.org/wiki/Q209727","display_name":"Palmitic acid","level":3,"score":0.3781000077724457},{"id":"https://openalex.org/C2779900937","wikidata":"https://www.wikidata.org/wiki/Q2442109","display_name":"Propionibacterium acnes","level":3,"score":0.33719998598098755},{"id":"https://openalex.org/C2910349174","wikidata":"https://www.wikidata.org/wiki/Q448310","display_name":"Seborrhoeic dermatitis","level":2,"score":0.33329999446868896},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.3327000141143799},{"id":"https://openalex.org/C2777056448","wikidata":"https://www.wikidata.org/wiki/Q285166","display_name":"Oral administration","level":2,"score":0.3188000023365021},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.31299999356269836},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.3073999881744385},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.3066999912261963},{"id":"https://openalex.org/C2778772119","wikidata":"https://www.wikidata.org/wiki/Q6058862","display_name":"Fatty liver","level":3,"score":0.305400013923645},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.2856999933719635},{"id":"https://openalex.org/C2776980637","wikidata":"https://www.wikidata.org/wiki/Q427492","display_name":"Enzyme inhibitor","level":3,"score":0.274399995803833},{"id":"https://openalex.org/C2776175330","wikidata":"https://www.wikidata.org/wiki/Q1365091","display_name":"Steatosis","level":2,"score":0.26739999651908875},{"id":"https://openalex.org/C2777459323","wikidata":"https://www.wikidata.org/wiki/Q5259911","display_name":"Human skin","level":2,"score":0.2612999975681305},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.260699987411499}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.25251/vh2hky50","doi":"https://doi.org/10.25251/vh2hky50","is_oa":true,"landing_page_url":"https://doi.org/10.25251/vh2hky50","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.25251/vh2hky50","doi":"https://doi.org/10.25251/vh2hky50","is_oa":true,"landing_page_url":"https://doi.org/10.25251/vh2hky50","pdf_url":null,"source":{"id":"https://openalex.org/S4210210594","display_name":"SKIN The Journal of Cutaneous Medicine","issn_l":"2574-1624","issn":["2574-1624"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","poland-20"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"SKIN The Journal of Cutaneous Medicine","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":2,"referenced_works":["https://openalex.org/W2980950801","https://openalex.org/W4255330100"],"related_works":[],"abstract_inverted_index":{"Background":[0],"and":[1,33,55,118,131,137,144,160,178,189,192,239,279,291,298,303,305,307,309,311,348,357,374,392,437,460,487],"Aims:bExcess":[2],"sebum":[3,31,155,165,485],"production":[4,32,147,177],"via":[5,168],"increased":[6],"de":[7,482],"novo":[8,483],"lipogenesis":[9],"(DNL)":[10],"contributes":[11],"to":[12,114,266,365,422],"acne":[13,61],"pathogenesis.":[14],"Fatty":[15],"acid":[16],"synthase":[17],"(FASN)":[18],"is":[19],"the":[20,24,39,285,359,379,382],"key":[21,40],"enzyme":[22],"in":[23,52,62,67,100,148,162,276,281,296,318,336,342,346,358,368,381,424],"DNL":[25,143],"pathway.":[26,43],"Inhibition":[27],"of":[28,59,82,251,287,323,332],"FASN":[29,48,171,466],"reduces":[30],"directly":[34,141],"decreases":[35],"inflammation":[36],"by":[37,93,410,480],"disrupting":[38],"inflammatory":[41,231],"signaling":[42],"Denifanstat":[44],"(deni),":[45],"an":[46,96,330],"oral":[47,472],"inhibitor,":[49],"was":[50,72,274,315,387,408,446],"tested":[51],"preclinical":[53,121,461],"models":[54],"evaluated":[56],"for":[57,389,394,475],"treatment":[58,195,272,324],"moderate-to-severe":[60],"Phase":[63,79],"3":[64,80],"clinical":[65,439,459],"trials":[66],"China.":[68],"Methods:":[69],"ASC40-303":[70],"(NCT06192264)":[71],"a":[73,205,257,425,470],"12-week,":[74],"randomized,":[75],"double-blind,":[76],"placebo":[77],"(pbo)-controlled":[78],"trial":[81],"deni":[83,108,185,226,234,243,252,343,363],"50":[84,109],"mg":[85,110],"once":[86],"daily":[87],"(n=240)":[88,91,106],"vs":[89,212,227,235,244,344,354],"pbo":[90,210,229,237,246,423],"followed":[92],"ASC40-304":[94,262],"(NCT06248008)":[95],"open-label":[97],"extension":[98],"(OLE)":[99],"which":[101],"participants":[102],"from":[103,128],"both":[104],"arms":[105],"received":[107],"through":[111,268,442],"week":[112,269,384,443],"52":[113,366],"assess":[115],"long-term":[116],"safety":[117],"efficacy.":[119],"In":[120,183,261],"studies,":[122],"primary":[123,188],"human":[124,129,149,163],"cells":[125],"were":[126,133,219,301,400],"isolated":[127],"blood,":[130],"sebocytes":[132],"Meisen":[134],"CTCC":[135],"Hum-280":[136],"SZ95.":[138],"Results:":[139],"Deni":[140,153,314,417,445],"inhibited":[142],"reduced":[145,154,174],"triglyceride":[146],"sebocyte":[150],"cell":[151,181],"lines.":[152],"palmitic":[156],"acid,":[157,159],"sapienic":[158],"triglycerides":[161],"skin":[164,203,350,371,391],"samples":[166],"collected":[167],"non-invasive":[169],"sebutape.":[170],"inhibitors":[172],"also":[173],"pro-inflammatory":[175],"cytokine":[176],"decreased":[179],"Th17":[180],"development.":[182],"ASC40-303,":[184,337],"met":[186],"all":[187,254],"secondary":[190],"endpoints":[191],"demonstrated":[193,418,431],"significant":[194,259,419,429],"success":[196,273],"(defined":[197],"as":[198,432,434],"clear":[199,202],"or":[200,334,402,454],"almost":[201],"with":[204,221,428],"\u22652-point":[206],"IGA":[207,271],"improvement)":[208],"versus":[209],"(33.2%":[211],"14.6%;":[213],"p<0.0001).":[214],"Mean":[215],"lesion":[216,293],"count":[217,294],"reductions":[218,295],"greater":[220],"deni:":[222],"total":[223],"lesions":[224,232,241],"\u221257.4%":[225],"\u221235.4%":[228],"(p<0.0001),":[230,238],"\u221263.5%":[233],"\u221243.2%":[236],"non-inflammatory":[240,292],"\u221251.9%":[242],"\u221228.9%":[245],"(p<0.0001).":[247],"After":[248],"4":[249,435],"weeks":[250,367,436],"treatment,":[253],"parameters":[255],"showed":[256],"statistically":[258],"benefit.":[260],"OLE,":[263],"efficacy":[264,420],"continued":[265],"improve":[267],"52.":[270,444],"57.8%":[275],"deni/deni":[277,297],"patients":[278,283,361],"55.6%":[280],"pbo/deni":[282,299],"at":[284,340,351,372,377],"end":[286],"treatment.":[288],"Total,":[289],"inflammatory,":[290],"groups":[300],"-73.0%,":[302],"-70.7%,":[304],"-78.1%":[306],"-75.8%,":[308],"-68.3%,":[310],"-65.5%,":[312],"respectively.":[313],"generally":[316,447],"well-tolerated":[317,448],"ASC40-303/304":[319],"trials.":[320],"Two":[321],"categories":[322],"related":[325,451],"adverse":[326],"events":[327],"(AEs)":[328],"had":[329],"incidence":[331,380],"5%":[333],"more:":[335],"dry":[338,349,370,375,390,395],"eye":[339,376],"10.9%":[341],"8%":[345],"pbo,":[347],"6.3%":[352],"(deni)":[353],"2.9%":[355],"(pbo),":[356],"239":[360],"receiving":[362],"up":[364],"ASC40-304:":[369],"7.1%":[373],"5.9%,":[378],"40":[383],"OLE":[385],"alone":[386],"2.5%":[388],"2.1%":[393],"eye.":[396],"All":[397],"deni-related":[398],"AEs":[399,453],"mild":[401],"moderate;":[403],"grade":[404,455],"1":[405,411],"hair":[406],"thinning":[407],"experienced":[409],"deni-treated":[412],"patient":[413],"during":[414],"OLE.":[415],"Conclusion:":[416],"compared":[421],"12-week":[426],"trial,":[427],"improvements":[430],"early":[433],"further":[438],"improvement":[440],"evident":[441],"without":[449],"drug":[450],"serious":[452],"\u22653":[456],"AE.":[457],"These":[458],"mechanistic":[462],"results":[463],"demonstrate":[464],"that":[465],"inhibition":[467],"can":[468],"offer":[469],"novel":[471],"therapeutic":[473],"approach":[474],"acne,":[476],"targeting":[477],"its":[478],"pathogenesis":[479],"reducing":[481],"lipogenesis,":[484],"production,":[486],"inflammation.":[488]},"counts_by_year":[],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2026-11-11T00:00:00"}